PART II.
OTHER INFORMATION



 20

Item 1.
Legal Proceedings.
From time to time the Company may also be involved in legal proceedings in the ordinary course of business.
The Company monitors the status of legal proceedings and other contingencies on an ongoing basis to ensure loss contingencies are recognized and/or disclosed in its financial statements and footnotes.
The Company does not believe there are any pending legal proceedings that are reasonably possible to result in a material loss.
Item 1A.
There have been no material changes from the risk factors previously disclosed in the 2018 10-K.
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
The following table provides information regarding repurchases of common stock made during the three months ended December 28, 2018:



[DATA_TABLE_REMOVED]



(1) The stock repurchase program approved by the Board of Directors on January 31, 2018, authorizes the repurchase of up to $1.0 billion of our common stock from time to time on the open market or in privately negotiated transactions as permitted by securities laws and other legal requirements.
On January 30, 2019, the Board of Directors approved a new $2.0 billion stock repurchase program that expires on January 30, 2021, and replaces in its entirety the January 31, 2018, plan.
(2) Represents shares repurchased by us at the fair market value of the common stock as of the applicable purchase date, in connection with the satisfaction of tax withholding obligations under equity award agreements.
(3) 1,250,000 shares were repurchased at an average price of $71.77 per share as part of our stock repurchase program, and 253,214 shares were repurchased by us at the fair market value of the common stock as of the applicable purchase date, in connection with the satisfaction of tax withholding obligations under equity award agreements with an average price of $77.11 per share.
(4) 2,750,000 shares were repurchased at an average price of $70.65 per share as part of our stock repurchase program, and 463 shares were repurchased by us at the fair market value of the common stock as of the applicable purchase date, in connection with the satisfaction of tax withholding obligations under equity award agreements with an average price of $69.56 per share.
On November 15, 2017, we agreed to potentially issue not more than 1% of our common stock to an unaffiliated third party as contingent consideration for its role under a multi-year collaboration agreement.
The shares are issuable for no cash payment but only upon the achievement of certain product sale milestones, certain terminations of the agreement or if the Company engages in 



 21

certain competition with the third party.
Though the timing is not certain, the Company does not expect achievement of the product sale milestones to occur any time prior to mid-2020.
The transaction was made in reliance on the exemption from registration in Section 4(a)(2) of the Securities Act.
The Company has agreed to file a registration statement with the Securities and Exchange Commission registering the resale of any issued shares.
22

Item 6.
Exhibits.
[DATA_TABLE_REMOVED]



 23
